The latest minimally invasive procedures and innovative radiation therapy provide Doylestown Hospital patients with the most advanced cancer treatment options available.
This minimally invasive surgery, performed by Doylestown Hospital urologic surgeons, removes the prostate gland while preserving the nerve and muscle groups that control sexual function and urinary control. Doylestown Hospital is one of only a few hospitals in southeastern Pennsylvania to offer this procedure.
Intensity Modulated Radiation Therapy (IMRT)
IMRT allows a radiation oncologist to deliver the prescribed dose of external radiation to the prostate gland so precisely that there is virtually no "spill-over" beyond the area being treated. This greatly reduces the incidence of undesirable side effects, including impotence.
Many men with early-stage prostate cancer are successfully treated with brachytherapy, a minimally invasive procedure. Radioactive "seeds" are implanted in the prostate, where they deliver a high dose of radiation to the tumor while reducing exposure to nearby healthy tissue.
For more information on perineal prostatectomy, IMRT, and brachytherapy, contact your urologist.
Liver, Kidney, Lung, and Bone Cancer
Radiofrequency Ablation (RFA)
Patients who are not candidates for surgery may benefit from RFA, a local treatment available at Doylestown Hospital that destroys small tumors with radiofrequency energy. The energy is transmitted to the tip of a needle inserted directly into the tumor, where it produces heat that kills the tumor. Currently used mostly for tumors in the liver, kidney, lung, and bone, RFA has been shown to improve quality of life and even prolong survival. Your oncologist can provide more information on RFA.
Hi-tech ‘oncotyping' helps tailor cancer treatment
A genomic test called ‘Oncotype DX' is currently used at Doylestown Hospital for patients with a specific type of breast cancer. (A genome contains the DNA within genes plus the chromosomes on which the genes are located.) "Through detailed computer analysis of 21 genes, oncotyping applies the statistics of the genomic make-up of known breast cancer tumors from across the country over the past 15 to 20 years to the genomic make-up of a new tumor," explains Doylestown Hospital oncologist Mitchell Alden, DO, The Cancer Institute of Doylestown Hospital program coordinator. "In practical terms, it's a tool that helps us determine which node-negative women need chemotherapy and who will do just as well without it. For patients seeking answers about the best course of treatment, this is extremely valuable information."
Needle Biopsy Rates
Established medical guidelines indicate that no more than 10 percent of breast biopsies should be surgical.
At Doylestown Hospital, the rate of surgical biopsy is around 5 percent, indicating that except in extenuating instances, the preferred method of needle biopsy is always used.
The Women's Diagnostic Center at Doylestown Hospital has earned the designation of a Breast Imaging Center of Excellence by the American College of Radiology (ACR). The breast imaging services at Doylestown Hospital are fully accredited in mammography, stereotactic breast biopsy, breast ultrasound and ultrasound-guided breast biopsy.
Needle biopsy, generally performed by a radiologist, has become the preferred method of extracting cells to check for breast cancer. Two types of needle biopsy that are frequently used are ultrasound guided core biopsy and stereotactic core biopsy. An ultrasound-guided biopsy relies on the ultrasound image to pinpoint the suspicious area. In a mammogram-guided, or stereotactic core biopsy, a special mammography machine guides the radiologist's instruments.
Both of these procedures are quick with minimal recovery for the patient. There is no sedation, anesthesia or stitches unlike a surgical biopsy. Only local anesthesia is used. The rates of accuracy for needle versus surgical biopsy are about the same. In a small number of instances, surgical biopsy is needed based on the patient's circumstances. However, for the majority of cases, needle biopsy is the method of choice. If a malignancy is found, the needle biopsy prevents the patient from having to undergo surgery twice.
While the initial diagnostic work might be done by a radiologist, the treatment may involve a range of specialists, including surgeons, radiologists, medical oncologists, radiation oncologists, pathologists and plastic-reconstructive surgeons. Doylestown Hospital offers access to all of these board-certified specialists.